| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G/A |
| 13 Nov 2026 | SCHEDULE 13G/A |
| 30 Oct 2026 | 10-Q |
| 28 Oct 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
HOUSTON (October 28, 2026)—Core Laboratories Inc. (NYSE: "CLB") ("Core," "Core Lab," or the "Company") reported third quarter 2026 revenue of $132,100,000. Core’s operating income was $12,100,000, with earnings per diluted share (“EPS”) ... |
| 05 Oct 2026 |
Form 4: Tattoli Mark Damian, SVP, Gen Counsel & Secretary
Gave up 276 shares to cover exercise price or tax ($2.69K) · Received 700 shares by exercise or conversion |
| 05 Oct 2026 |
Form 4: Teo Sow Hang, CAO & Treasurer
Gave up 99 shares to cover exercise price or tax ($966) · Received 250 shares by exercise or conversion |
| 25 Aug 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
I write to inform you of my decision to resign from my position as a member of the Board of Directors of Core Laboratories, where I am the chairman of the Nominating, Governance, and Sustainability Committee, and member of the Compensati... |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 06 Aug 2026 | SCHEDULE 13G/A |
| 04 Aug 2026 |
Form 4: Bruno Lawrence, Director
Bought 5,000 shares ($53.9K) |
| 04 Aug 2026 |
Form 4: Teo Sow Hang, CAO & Treasurer
Gave up 198 shares to cover exercise price or tax ($2.11K) · Received 440 shares by exercise or conversion |
| 04 Aug 2026 |
Form 4: Tattoli Mark Damian, SVP, Gen Counsel & Secretary
Gave up 99 shares to cover exercise price or tax ($1.05K) · Received 250 shares by exercise or conversion |
| 30 Jul 2026 | 10-Q |
| 29 Jul 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
HOUSTON (July 29, 2026)—Core Laboratories Inc. (NYSE: "CLB") ("Core," "Core Lab," or the "Company") reported second quarter 2026 revenue of $124,600,000. Core’s operating income was $9,200,000, with earnings per diluted share (“EPS”) of ... |
| 29 Jun 2026 | 11-K |
| 15 May 2026 | SCHEDULE 13G/A |
| 15 May 2026 | SD |
| 13 May 2026 |
8-K: Submission of Matters to a Vote of Security Holders
Core Laboratories Inc. (the “Company”) held its Annual Meeting of Shareholders (the “Annual Meeting”) on May 12, 2026 in Houston, Texas. At the Annual Meeting, the Company’s shareholders were asked to vote on the following proposals: (1)... |
| 04 May 2026 |
Form 4: Tattoli Mark Damian, SVP, Gen Counsel & Secretary
Gave up 97 shares to cover exercise price or tax ($1.36K) · Received 250 shares by exercise or conversion |
Loading...